Lumiata raises $5M to further its optimized medical-care analytics

In case it wasn’t clear already, big data is attracting a lot of attention from investors. You can see this recent injection of capital into Lumiata, bringing its total investments to $9 million.

According to an SEC filing dated for Aug. 11, the predictive analytics company that uses a medical graph for making smarter care decisions raised $5 million in equity funding.

[aditude-amp id="flyingcarpet" targeting='{"env":"staging","page_type":"article","post_id":1537610,"post_type":"story","post_chan":"none","tags":null,"ai":false,"category":"none","all_categories":"entrepreneur,","session":"A"}']

The Lumiata “Graph” provides care providers with predictive analytics based on a variety of factors including location, time, behavior, and pathophysiology. Staff at all levels of the medical industry — we’re talking doctors, nurses, health insurance companies, and more — can use the data to make decisions about patient wellness, diagnoses, triage, and more. It also makes identifying gaps in data easier to spot.

The analytics are available thanks to APIs that works in a number of situations and on numerous devices.

Back in January, the company raised $4 million in its first round of series A funding. The primary investor was Khosla Ventures. That round of funding went toward improving the company flagship analytics engine and expand to more hospital networks and health insurance carriers.

Lumiata, formerly known as MEDgle, was founded in 2013 by Ash Damle, the startup’s current chief executive. It’s based in San Mateo, Calif.